EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Determination of glomerular filtration rate “en passant” after high doses of iohexol for computed tomography in intensive care medicine—a proof of concept

Alexander Dejaco, Christoph Dorn, Michael Paal, Michael Gruber, Bernhard M Graf, Martin G Kees

Frontiers in Pharmacology · 01.02.2024 · 15

DOI: 10.3389/fphar.2024.1346343 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Pharmacology, online erschienen am 01.02.2024. Verfasst von Alexander Dejaco und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesia, University Hospital Regensburg, Regensburg, Germany. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Accurate assessment of renal function is of great clinical and scientific importance, as it is an important pharmacokinetic covariate of pivotal drugs. The iohexol clearance is nearly identical to the glomerular filtration rate, but its determination usually requires an intravenous injection and therefore bears intrinsic risks. This motivates to showcase an “en passant” approach to quantification of renal function without additional risk or blood sampling beyond routine care using real-world data. We enrolled 37 intensive care patients who received high doses of iohexol for computed tomography imaging, and quantified series of iohexol plasma concentrations by high-performance liquid chromatography (HPLC-UV). Iohexol clearance was derived by both log-linear regression and nonlinear least squares fitting and compared to glomerular filtration rate estimated by the CKD-EPI-2021 formulas. Nonlinear fitting not only turned out to be more accurate but also more robust in handling the irregularly timed data points. Concordance of iohexol clearance against estimations based on both creatinine and cystatin C showed a slightly higher bias (−3.44 mL/min/1.73 m 2 ) compared to estimations based on creatinine alone (−0.76 mL/min/1.73 m 2 ), but considerably narrower limits of agreement (±42.8 vs. 56 mL/min/1.73 m 2 ) and higher Lin’s correlation (0.84 vs. 0.72). In summary, we have demonstrated the feasibility and performance of the “en passant” variant of the iohexol method in intensive care medicine and described a working protocol for its application in clinical practice and pharmacologic studies.

Schlagwörter

Stichwörter der Autor:innen

contrast-enhanced computed tomography imagingestimated glomerular filtration rate (eGFR)intensive care medicine (ICM)measured glomerular filtration rate (mGFR)pharmacokinetic studies“en passant” iohexol clearance

Autor:innen und Institutionen

  • Department of Anesthesia, University Hospital Regensburg, Regensburg, Germany.
  • Institute of Pharmacy, University of Regensburg, Regensburg, Germany.
  • Institute for Laboratory Medicine, Hospital of the University of Munich (LMU), Munich, Germany.

Zitieren

APA

Dejaco, A., Dorn, C., Paal, M., Gruber, M., Graf, B. M., & Kees, M. G. (2024). Determination of glomerular filtration rate “en passant” after high doses of iohexol for computed tomography in intensive care medicine—a proof of concept. Frontiers in Pharmacology, 15. https://doi.org/10.3389/fphar.2024.1346343

Vancouver

Dejaco A, Dorn C, Paal M, Gruber M, Graf BM, Kees MG. Determination of glomerular filtration rate “en passant” after high doses of iohexol for computed tomography in intensive care medicine—a proof of concept. Frontiers in Pharmacology. 2024;15. doi:10.3389/fphar.2024.1346343

BibTeX
@article{Dejaco2024,
  author = {Dejaco, Alexander and Dorn, Christoph and Paal, Michael and Gruber, Michael and Graf, Bernhard M and Kees, Martin G},
  title = {Determination of glomerular filtration rate “en passant” after high doses of iohexol for computed tomography in intensive care medicine—a proof of concept},
  journal = {Frontiers in Pharmacology},
  year = {2024},
  volume = {15},
  doi = {10.3389/fphar.2024.1346343}
}
Kostenlos starten →